Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)
Close on Nov 17, 2026Market cap $41.33MP/E –Yield –
Harvard Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Harvard Bioscience's enterprise value was $74.25M on Nov 11, 2026, against $27.11M a year earlier. Over the last 5 years it ranged from $12.08M to $327.65M, with a median of $156.14M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $74.25M | +222.8% |
| 2025 | Dec 31, 2025 | $23.00M | -81.7% |
| 2024 | Dec 31, 2024 | $125.71M | -52.0% |
| 2023 | Dec 29, 2023 | $262.07M | +64.0% |
| 2022 | Dec 30, 2022 | $159.78M | -51.2% |
| 2021 | Dec 31, 2021 | $327.65M | +57.3% |
| 2020 | Dec 31, 2020 | $208.26M | +29.4% |
| 2019 | Dec 31, 2019 | $160.96M | -6.0% |
| 2018 | Dec 31, 2018 | $171.16M | +43.9% |
| 2017 | Dec 29, 2017 | $118.94M | +6.0% |
| 2016 | Dec 30, 2016 | $112.16M | -11.6% |
| 2015 | Dec 31, 2015 | $126.85M | -27.5% |
| 2014 | Dec 31, 2014 | $175.04M | +21.1% |
| 2013 | Dec 31, 2013 | $144.51M | +17.0% |
| 2012 | Dec 31, 2012 | $123.56M | +17.1% |
| 2011 | Dec 30, 2011 | $105.55M | -0.0% |
| 2010 | Dec 31, 2010 | $105.59M | – |
See a number that looks wrong?